VEGFA and hepatocellular carcinoma: Ectopic expression of miR-125a can inhibit the proliferation, invasion and metastasis of HCC by down-regulating MMP11 and VEGF in vitro and in vivo, and thus, miR-125a represents a new prognosis marker and a promising approach for HCC treatment.